June 17, 2026
What's the read on Indian equities, and where are experts most and least constructive?
Experts are broadly cautious on Indian equities due to significant overvaluation, though they identify specific long-term sectoral opportunities [1, 22]. Aswath Damodaran characterizes the Indian market as the most overvalued globally, citing its high P/E ratio [6, 15]. This valuation is not solely based on fundamentals but is driven by powerful psychological and structural factors: "Fear Of Missing Out" (FOMO) from foreign institutional investors seeking the "next China," and a captive domestic investor base with limited options for deploying growing wealth due to regulatory restrictions [2, 6, 20, 27]. This sentiment-driven valuation is vulnerable to shifts in capital flows . Recent market performance reflects this fragility, with foreign investors being net sellers for the year and the market having lost **$639 billion** in value since the start of a recent conflict [26, 29]. This is compounded by macro risks, including a fracturing post-WWII global economic order, the uncertainty of potential tariffs, and India's position as a large oil importer, which makes it a market laggard in the region [4, 5, 19, 30].
Despite the bearish macro view, analysts are most constructive on specific long-term growth sectors within India, particularly healthcare and artificial intelligence services [7, 24]. As the population's discretionary income rises, spending on healthcare is expected to grow significantly, creating opportunities for companies that can develop innovative delivery models tailored to the Indian context [7, 9]. Damodaran draws a parallel to the U.S., where healthcare spending accounts for 20% of GDP, suggesting a large runway for growth in India [8, 13, 28]. In artificial intelligence, the primary opportunity is not in the capital-intensive chip architecture space but in developing monetizable B2B AI products and services [2, 14, 24]. While a half-a-trillion dollars has been invested in AI architecture globally, this is predicated on an expected **$4 trillion** market for AI products and services, a field that remains "wide open" for new entrants, including Indian firms [12, 17].
Go deeper
Search this topic across 400+ expert conversations on Sonic.
Even within promising sectors, investors must be wary of company-specific risks that are not reflected in broad market narratives [3, 18]. For example, investors in a company like Zomato may not be factoring in the inevitable margin compression that will occur as it expands from high-margin restaurant delivery to low-margin grocery delivery [3, 18]. This underscores the difficulty of active stock selection in a market where, according to Damodaran, **80% of Indian mutual funds** underperform their index . For most retail investors, the recommended strategy is a disciplined, long-term approach using low-cost index funds rather than speculative trading, focusing on wealth preservation and steady growth [2, 11].
What the sources say
Points of agreement
- •Multiple experts agree that the Indian equity market is overvalued or expensive.
- •Sources highlight that foreign investors have been net sellers of Indian equities, making the market vulnerable to shifts in capital flows.
- •Experts point to significant macroeconomic risks, including geopolitical uncertainty and India's vulnerability as a large oil importer.
Points of disagreement
- •While there is general caution on the market's high valuation, Aswath Damodaran identifies specific long-term growth opportunities in sectors like healthcare and B2B AI services.
- •One view attributes overvaluation to psychological drivers like FOMO and a lack of domestic investment alternatives, while another cites fundamental concerns like declining earnings.
- •Some sources focus on recent market downturns and foreign selling, whereas others analyze the more persistent, structural reasons for the market's high valuation.
Sources
Keeping My Eyes Open For These Stocks…: Aswath Damodaran On Indian Markets, Valuations & Tariffs
This source provides Aswath Damodaran's detailed view that the Indian market is overvalued due to psychological factors, while also highlighting long-term opportunities in healthcare and AI services.
Stock Selloff Extends on Tech, Oil Rises on Iran | Bloomberg Daybreak: Asia Edition
This source contributes the perspective that Matthews Asia is cautious on India due to high expense, declining earnings, and a lack of near-term growth drivers.
AI Powers Stock Records, Still No Iran Deal, Europe's Rush to Re-arm | Bloomberg Daybreak:...
This source notes that South Asian markets, including India, are down for the year and experiencing extended periods of net selling by foreign investors.
Interview: Raghuram Rajan Exclusive With Rajdeep Sardesai On Indian Economy And Iran War
This source quantifies a recent market loss of $639 billion, linking it directly to a geopolitical conflict.
Asian Stocks Rise, US Hits Record on Iran Talks Hopes | Bloomberg Daybreak: Asia Edition
This source identifies India as a market laggard in Asia because it is a large importer of oil.
Related questions
What are the key drivers behind the declining earnings cited by Matthews Asia?
→Which specific Indian companies are developing innovative healthcare delivery models or monetizable B2B AI services?
→How are domestic investment flows impacting market valuation amidst net selling by foreign investors?
→What are the specific regulatory restrictions limiting Indian domestic wealth from being invested abroad?
→Ask your own research questions
Search and synthesize across 400+ expert conversations in real time.
Try: “What's the read on Indian equities, and where are experts most and least constructive?”
Search this on Sonic →